Works matching IS 17568722 AND DT 2025 AND VI 18 AND IP 1

Results: 74
    1
    2
    3
    4

    BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01721-2
    By:
    • Chen, Yijin;
    • Huo, Dawei;
    • Meng, Ye;
    • Zhang, Jie;
    • Huang, Mengmeng;
    • Luo, Qian;
    • Xu, Yulin;
    • Zheng, Haiqiong;
    • Han, Yingli;
    • Zeng, Xiangjun;
    • Liu, Yanjuan;
    • Liu, Yunfei;
    • Wen, Rui;
    • Kong, Delin;
    • Tie, Ruxiu;
    • Pei, Shanshan;
    • Liu, Nan;
    • Qian, Pengxu;
    • Huang, He;
    • Zhang, Meng
    Publication type:
    Article
    5

    CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01715-0
    By:
    • Tirado, Néstor;
    • Fidyt, Klaudyna;
    • Mansilla, María José;
    • Garcia-Perez, Alba;
    • Martínez-Moreno, Alba;
    • Vinyoles, Meritxell;
    • Alcain, Juan;
    • García-Peydró, Marina;
    • Roca-Ho, Heleia;
    • Fernandez-Fuentes, Narcis;
    • Guerrero-Murillo, Mercedes;
    • Falgàs, Aïda;
    • Velasco-Hernandez, Talia;
    • Bueno, Clara;
    • Panelli, Patrizio;
    • Mulens-Arias, Vladimir;
    • Apostolov, Apostol;
    • Engel, Pablo;
    • González, Europa Azucena;
    • Vick, Binje
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01705-2
    By:
    • Ouyang, Quchang;
    • Rodon, Jordi;
    • Liang, Yan;
    • Wu, Xinhong;
    • Li, Qun;
    • Song, Lihua;
    • Yan, Min;
    • Tong, Zhongsheng;
    • Liu, YunPeng;
    • Wainberg, Zev A.;
    • Wang, Ying;
    • Geng, Cuizhi;
    • Ulahannan, Susanna V.;
    • Yu, Guohua;
    • Sharma, Manish R.;
    • Wang, Xiang;
    • Wang, Judy S.;
    • Spira, Alexander;
    • Zhao, Weihong;
    • Sanborn, Rachel E.
    Publication type:
    Article
    17

    Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01712-3
    By:
    • Lin, Yunqing;
    • Xiao, Ziyun;
    • Hu, Fangxiao;
    • Zheng, Xiujuan;
    • Zhang, Chenyuan;
    • Wang, Yao;
    • Liu, Yanhong;
    • Huang, Dehao;
    • Wang, Zhiqian;
    • Xia, Chengxiang;
    • Weng, Qitong;
    • Zhang, Leqiang;
    • Zhao, Yaoqin;
    • Qi, Hanmeng;
    • Shen, Yiyuan;
    • Chen, Yi;
    • Zhang, Fan;
    • Wu, Jiaxin;
    • Liu, Pengcheng;
    • Xu, Jiacheng
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01697-z
    By:
    • Hong, Huangming;
    • Chen, Zegeng;
    • Zhang, Mingzhi;
    • Peng, Zhigang;
    • Shen, Jianzhen;
    • Shuang, Yuerong;
    • Zhou, Hui;
    • Guo, Hongqiang;
    • Huang, He;
    • Li, Fei;
    • Qian, Zhengzi;
    • Liu, Lihong;
    • Wang, Liang;
    • Yang, Wei;
    • Zhang, Liling;
    • He, Pengcheng;
    • Qian, Shen;
    • Li, Fugen;
    • Li, Meng;
    • Lin, Tongyu
    Publication type:
    Article
    25

    PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01700-7
    By:
    • Zeremski, Vanja;
    • Haage, Tobias R.;
    • Witte, Hanno M.;
    • Adolph, Louisa;
    • Beer, Sina A.;
    • Behre, Gerhard;
    • Jacobs, Benedikt;
    • Kahl, Christoph;
    • Lalayanni, Chrysavgi;
    • Panse, Jens;
    • Papageorgiou, Sotirios;
    • Siakantaris, Marina P.;
    • Schneider, Jessica;
    • Schnetzke, Ulf;
    • Schulz, Alexander;
    • Vassilakopoulos, Theodoros P.;
    • Walter, Jeanette;
    • Mougiakakos, Dimitrios
    Publication type:
    Article
    26
    27
    28

    KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01696-0
    By:
    • Yousef, Mahmoud;
    • Yousef, Abdelrahman;
    • Hurd, Mark W.;
    • Pillai, Ashwathy;
    • Chowdhury, Saikat;
    • Snyder, Rebecca;
    • Knafl, Mark;
    • Lewis, Ryan L.;
    • Roy, Paul M.;
    • Fanaeian, Mohammad;
    • Albarouki, Sali;
    • Castelnovo, Luca F.;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Willis, Jason;
    • Huey, Ryan;
    • Overman, Michael;
    • Tzeng, Ching-Wei
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

    Published in:
    2025
    By:
    • Berneman, Zwi N.;
    • De Laere, Maxime;
    • Germonpré, Paul;
    • Huizing, Manon T.;
    • Willemen, Yannick;
    • Lion, Eva;
    • De Reu, Hans;
    • Van den Bossche, Jolien;
    • Van den Brande, Jan;
    • Specenier, Pol;
    • Altintas, Sevilay;
    • van Dam, Peter A.;
    • Cools, Nathalie;
    • Nijs, Griet;
    • Stein, Barbara;
    • Caluwaerts, Kim;
    • Snoeckx, Annemiek;
    • de Beeck, Bart Op;
    • Saevels, Kirsten;
    • Rutsaert, Lynn
    Publication type:
    Correction Notice
    40
    41
    42
    43
    44
    45
    46

    Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01676-4
    By:
    • Umyarova, Elvira;
    • Pei, Charles;
    • Pellegrino, William;
    • Zhao, Qiuhong;
    • Sharma, Nidhi;
    • Benson, Don;
    • Cottini, Francesca;
    • Bezerra, Evandro;
    • Brammer, Jonathan;
    • Bumma, Naresh;
    • Choe, Hannah;
    • Denlinger, Nathan;
    • Devarakonda, Srinivas;
    • Khan, Abdullah;
    • Penza, Sam;
    • Rosko, Ashley;
    • Vasu, Sumithira;
    • Wall, Sarah;
    • Alinari, Lapo;
    • Baiocchi, Robert
    Publication type:
    Article
    47
    48
    49
    50